A Response to “Equipoise Is No Longer a Major Consideration in the Ethical Evaluation of Phase 3 Randomized Controlled Trials Involving Precision Oncology Approaches in NSCLC”

Sarah Heynemann; Wendy Lipworth; Sue-Anne McLachlan; Jennifer Philip; Tom John; Ian Kerridge

doi:10.1016/j.jtho.2024.12.017

A Response to “Equipoise Is No Longer a Major Consideration in the Ethical Evaluation of Phase 3 Randomized Controlled Trials Involving Precision Oncology Approaches in NSCLC”

Sarah Heynemann^*, Wendy Lipworth, Sue-Anne McLachlan, Jennifer Philip, Tom John, Ian Kerridge

^*Corresponding author for this work

School of Humanities

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e51-e52
Number of pages	2
Journal	Journal of Thoracic Oncology
Volume	20
Issue number	4
DOIs	https://doi.org/10.1016/j.jtho.2024.12.017
Publication status	Published - Apr 2025

Access to Document

10.1016/j.jtho.2024.12.017

Cite this

@article{41c661de9bcb4fa3b9290fa2e154e6c3,

title = "A Response to “Equipoise Is No Longer a Major Consideration in the Ethical Evaluation of Phase 3 Randomized Controlled Trials Involving Precision Oncology Approaches in NSCLC”",

author = "Sarah Heynemann and Wendy Lipworth and Sue-Anne McLachlan and Jennifer Philip and Tom John and Ian Kerridge",

year = "2025",

month = apr,

doi = "10.1016/j.jtho.2024.12.017",

language = "English",

volume = "20",

pages = "e51--e52",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Lippincott Williams & Wilkins",

number = "4",

}

A Response to “Equipoise Is No Longer a Major Consideration in the Ethical Evaluation of Phase 3 Randomized Controlled Trials Involving Precision Oncology Approaches in NSCLC”. / Heynemann, Sarah; Lipworth, Wendy; McLachlan, Sue-Anne et al.
In: Journal of Thoracic Oncology, Vol. 20, No. 4, 04.2025, p. e51-e52.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - A Response to “Equipoise Is No Longer a Major Consideration in the Ethical Evaluation of Phase 3 Randomized Controlled Trials Involving Precision Oncology Approaches in NSCLC”

AU - Heynemann, Sarah

AU - Lipworth, Wendy

AU - McLachlan, Sue-Anne

AU - Philip, Jennifer

AU - John, Tom

AU - Kerridge, Ian

PY - 2025/4

Y1 - 2025/4

UR - http://www.scopus.com/inward/record.url?scp=105001495603&partnerID=8YFLogxK

U2 - 10.1016/j.jtho.2024.12.017

DO - 10.1016/j.jtho.2024.12.017

M3 - Letter

C2 - 40204396

AN - SCOPUS:105001495603

SN - 1556-0864

VL - 20

SP - e51-e52

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 4

ER -

A Response to “Equipoise Is No Longer a Major Consideration in the Ethical Evaluation of Phase 3 Randomized Controlled Trials Involving Precision Oncology Approaches in NSCLC”

Access to Document

Other files and links

Cite this